The prevalence of non-tuberculous mycobacterial (NTM) lung disease in the United States has almost doubled between 2008 and 2015. But despite this increase, its diagnosis can often be delayed, which is why pulmonary nurse practitioner Amy Levinger and Dr. David Griffith join Dr. Tim Aksamit to discuss the diagnostic criteria, tools that can help us make a timely diagnosis of NTM lung disease, and more.
For more information and to access clinician & patient tools about NTM and MAC Lung Disease, click here to visit the CHEST Foundation NTM webpage.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.